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Platelet response to clopidogrel and prasugrel was assessed by the VerifyNow
assay and light transmission aggregrometry. Response to treatment and rate of
high platelet reactivity (HPR) and inhibition (HPI) were compared between
the two age categories.
Results: On-treatment platelet reactivity with clopidogrel 75mg, 150mg or
prasugrel 10mg was always higher in elderly patients (n=197) than in younger
patients (n=1074) whatever the test used. The difference in PRU in response
to ADP-PGE1 agonist between the two populations was +45; p<0.0001 in
patients treated with clopidogrel 75mg, +30; p=0.17 in patients treated with
clopidogrel 150mg and +20; p=0.08 with prasugrel 10mg. Elderly patients dis-
played a higher rate of HPR on clopidogrel 75mg than younger patients
(38.2% vs. 18.2%; p<0.0001) (figure) and a lower rate of HPI (2.3% vs. 8.7%;
p=0.01). Of note, diabetes and the distribution of the genotype for the loss of
function allele 2C19*2 were similar in both population and could not explain
the higher rate of HPR of the elderly.
Conclusions: Elderly patients present an impaired response to clopidogrel
with a high rate of HPR. Clopidogrel 150mg and prasugrel 10mg blunt, but do
not eliminate the difference in response observed between old and young
patients.
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Background: Risk of myocardial infarction (MI) in HIV infected patients
is increased and short term prognosis is good. One year outcome remain to be
determined in large scale study. 
Methods: From the French nationwide hospital medical information data-
base, all the consecutive patients hospitalized in the 1546 French hospital/
clinics for myocardial infarction from 1st January 2005 to 31st December
2009 were included. We compared one year outcome between patients
infected or not by HIV.
Results: Among the 628454 patients included, 1286 (0.2%) was infected
by HIV. At one year of follow-up, we observed an increased rate of recurrent
MI in HIV-infected patients than non-infected patients (14,9% vs 12.9%;
p=0.02) and respectively 14.9% vs 11.3% (p<0.01) in a sub-group of patients
matched for age, sex and type of MI (ratio 1:2).
Conclusion: From our large scale nationwide study, HIV patients have an
increased risk of recurrent MI during follow-up, thus emphasizing the benefit
of secondary prevention in such patients.
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Introduction: Iatrogenic event was defined as adverse drug reactions or
complications induced by non-drug interventions, such as cardiac devices or
stimulation techniques. Iatrogenic complications (IC) are associated with pro-
longed hospitalization and higher in hospital mortality. In the real world IC is
mainly evaluated during hospital stay. The present study focused on admission
in a coronary care unit (CCU) for an adverse effect and we aimed: a) to eval-
uate the prevalence and the characteristics of these admissions and the types
of iatrogeny; b) and to assess the in-hospital mortality.
Methods: From April 2008 to April 2011, all the consecutive admissions
caused by iatrogenic events at the CCU were prospectively studied and classified
in 2 groups: 1) pharmacological adverse effect (antiarrythmics, anticoagulant, and
antiplatelets), 2) non pharmacological adverse effect (pace maker, Automatic
Implantable Cardiovertor Defibrillator, radiofrequency, stent, cardiac surgery).
Results: On 5517 admissions, 168 (3 %) iatrogenic causes of admissions
were included. Most patients were male (54%) with a mean age at
71±16 years. The iatrogenic in-hospital mortality (7.7 %) was similar to gen-
eral population (8 %). The following table presents the results of the 2 groups.
Table – The results of the 2 groups 
Conclusion: This preliminary work shows the high frequency of iatrogenic
events induced admissions and the high rate of hospital death in particular for
non drug interventions, which tend toward a worse prognosis. The follow up
of this work will be necessary to better understand the causes of iatrogeny in
order to limit this pathology.
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Patients with HPR under thienopyridine treatment
N 
(%)
Men Age±S
D
Hospital 
death 
rate
Total 168 90 
(54%)
71±16 14 (8%)
1 Pharmacological adverse 
effect
84
(50%)
34
(40%)
75±14 4(5%)
2 Non pharmacological 
adverse effect
84
(50%)
56 
(67%)
68±17 10(12%)
p NS p<0.001 p=0.004 P=0.163
